Hidradenitis suppurativa (HS) demonstrates a disproportionately higher prevalence in Black patients, characterized by more severe disease, extended diagnostic delays, and increased healthcare utilization. Recognizing inflammation and post-inflammatory pigment alterations within skin of color is crucial for assessing disease severity. Understanding these changes in pigmentation provides a key to evaluating the extent of the condition.
Clinical Considerations and Risk Factors
According to Julia M. Riley, MD, of Northwestern University Feinberg School of Medicine, the presentation also addressed the elevated risk of keloids associated with HS, noting their potential development at the site of the HS lesion in response to inflammation, and their possibility following surgical procedures such as de-roofing. Patient access to care is identified as a multifactorial challenge, encompassing systemic issues like insurance barriers and lengthy dermatology appointment waits.
Management and Patient Preferences
Effective communication and readily available access to healthcare providers, through systems like MyChart or messaging, are emphasized to manage chronic disease and address flares characterized by worsening pain, drainage, and a significant impact on quality of life. Furthermore, the discussion included addressing biologic hesitancy among patients. Keloid formation after surgical excisions is a concern, particularly in individuals with a history of keloids or predisposition to them. Intralesional steroid injections are frequently utilized to manage keloid symptoms or flatten lesions. Patient preference often favors keloid scars over the original HS lesions following surgical treatment.